Contact Us

Phenylpropanolamine PPA
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

State where drug was ingested:

What product(s) was/were used containing PPA?

Was the injury a stroke/brain hemorrhage?

What date did stroke or hemorrhage occur?

If yes, what type of stroke/brain hemorrhage was suffered?

If you checked Ischemic, did injured party have Atrial Fibrillation?

How many days after using the PPA product did injured party suffer the stroke/hemorrhage?

How often was this medication used and when was it last used?

Does injured party still have this medication?

What additional medications were you taking at the time?

Have you taken the diet drug Meridia?

Please describe any residual damages resulting from stroke (paralysis, slurred speech, memory loss):

If stroke was suffered, has any doctor given his/her opinion as to the cause of the stroke?

If injured party did NOT have a stroke, what injuries were suffered as a result of PPA?

Please further describe side effects:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

PPA

PPA Side Effects Lawsuits | Side Effects: Hemorrhagic Strokes, Bleeding In Brain
CLICK HERE TO DOWNLOAD OUR INFORMATION PACKAGE

PPA Side Effects Could Lead To Stroke Lawsuits

PPA | Lawsuits, Lawyers | Side Effects: Hemorrhagic Strokes, Bleeding In Brain

Phenylpropanolamine (PPA) has been linked to dangerous side effects that cause hemorrhagic strokes. PPA is a chemical that was the active ingredient in numerous over the counter and prescription diet drugs, nasal decongestants and cough medications such as Dexatrim, Acutrim, Robitussin, Comtrex, Triaminic, and Tavist D.  In 1990, U.S. consumers bought about 6 billion doses of medication that contained PPA.

In November 2000, U.S. regulators first moved to take Phenylpropanolamine off the market due to the serious side effects. The Food and Drug Administration said it has asked all drug companies to voluntarily stop marketing products containing PPA and is seeking to make the sale of PPA products, both prescription and over-the-counter, illegal. While research pointed to a higher risk of hemorrhagic strokes, or bleeding into the brain, for women, the FDA cautioned that men were also at risk. The strokes occurred within three days after people took the products.

Legal Help For Victims Affected By PPA

If you or a loved one took a product containing Phenylpropanolamine (PPA) and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects lawyers or call us at 1-800YOURLAWYER (1-800-968-7529).



 

El Pasoan Gets $400,000 In Lawsuit Against Bayer

Oct 17, 2004 | AP
An El Paso jury awarded $400,000 to a man who blamed a chemical formerly used in Alka-Seltzer Plus for a stroke he suffered in 1997. The verdict for Miguel Valverde was delivered in El Paso County Court-at-Law No. 5 on Wednesday against Bayer Corp., the company that makes the cold remedy. The jury decided that Bayer was not negligent or malicious but said that the product had a "design defect" and that a "safer alternative design" was available that would have prevented or significantly reduced...

Legal Blow Prompts Bayer Warning On Settlements

Oct 15, 2004 | The Times, UK
BAYER, the German chemicals to healthcare giant, last night admitted that it may need to set aside extra provisions as it said it would consider settling lawsuits from US claimants who suffered strokes after taking cold remedies containing one of its chemicals. A spokesman for the company told The Times that Bayer might have to compensate as many as 1,200 Americans who suffered severe strokes after taking phenylpropanolamine (PPA). The chemical, which was used in more than 30 different products...

Drug Agency Bans 167 Cold Medicines Over Stroke Risk

Aug 2, 2004 | The Korean Herald
The government ordered a ban on the prescription and manufacturing of cold medicines containing Phenylpropanolamine yesterday, citing risk of brain stroke, especially among women. Nearly 170 medicines manufactured or imported by 75 companies are subject to the government interdiction, the Korea Food & Drug Administration said. The major companies included Yuhan Corporation, Choongwae Pharma Corp., Daewoong Co. and Hyundai Pharm. PPA is an ingredient that was used in many over-the-counter...

FDA Warns of Over-the-Counter Drug

Mar 5, 2004 | AP
The Food and Drug Administration warned Americans Monday not to use dozens of over-the-counter cold remedies or appetite suppressants until their makers replace an ingredient that could cause hemorrhagic strokes, especially in young women.The ingredient, called phenylpropanolamine or PPA, is found in products ranging from Dexatrim to Triaminic.The FDA said it is taking steps to formally ban PPA, but in the meantime wrote manufacturers asking them voluntarily to immediately quit selling products...

Lawsuit Over OTC-Drug Ingredient Begins

Nov 16, 2003 | The Star Ledger
Five years ago, Rosemary Krenfeld took a popular nasal decongestant called Tavist-D, which was regularly sold without a prescription. She later suffered a stroke and, since then, the 48-year-old mother of three has been confined to a wheelchair. Tomorrow, her lawyers will argue in Superior Court in New Brunswick that her problems can be traced to Tavist-D and the manufacturer, Novartis Pharmaceuticals, knew a key ingredient was linked to hemorrhagic strokes, especially in young women. The...

More PPA News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo